Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats.

作者: Bruna Gigante , Ornella Piras , Paola De Paolis , Antonio Porcellini , Armando Natale

DOI: 10.1097/00004872-199816121-00027

关键词: StimulationReceptorAngiotensin receptorBlockadeMedicineMechanism of actionAngiotensin IIInternal medicineLosartanBlood pressureEndocrinology

摘要: Objective The aim of this study was to evaluate the potential role angiotensin II (Ang II) AT 2 receptors (AT ) in control blood pressure (BP) rat and effects on BP during AT, receptor (AT,) antagonism. Methods performed 52 Sprague-Dawley rats, which were preliminarily salt-restricted (SR) enhance circulating tissue renin-angiotensin system activity. To explore whether plays a regulation, selective 1 antagonists PD123319 (PD) (50 μg/kg/min) losartan (Los) (10 mg/kg/day), studied. Seven rats used as group. define response observed antagonism, 17 Los treated divided into two groups: seven with both (Los + PD) 10 received vehicle. drugs also studied bilaterally nephrectomized (NX). All treatments maintained for week. Results reduced significantly intact (P < 0.001) NX 0.05) while PD increased (both P 0.001). In group levels higher 0.001 vs vehicle, = ns pretreatment), vehicle infusion did not modify Los. Conclusion results show that blockade offsets BP-lowering effect suggest contribute hypotensive losartan. Thus, such losartan, are becoming widely clinical treatment hypertension, may reduce only by receptors, but through stimulation excess II.

参考文章(20)
David Macari, Serge Bottari, Steven Whitebread, Marc De Gasparo, Nigel Levens, Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat. European Journal of Pharmacology. ,vol. 249, pp. 85- 93 ,(1993) , 10.1016/0014-2999(93)90665-5
T. J. Murphy, R. Wayne Alexander, Kathy K. Griendling, Marschall S. Runge, Kenneth E. Bernstein, Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor Nature. ,vol. 351, pp. 233- 236 ,(1991) , 10.1038/351233A0
K Sassaki, Y Yamono, S Bardhan, N Iwai, JJ Murray, M Hasegawa, Y Matsuda, T Inagami, None, Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor Nature. ,vol. 351, pp. 230- 233 ,(1991) , 10.1038/351230A0
Jan Kajstura, Elena Cigola, Ashwani Malhotra, Peng Li, Wei Cheng, Leonard G. Meggs, Piero Anversa, Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro Journal of Molecular and Cellular Cardiology. ,vol. 29, pp. 859- 870 ,(1997) , 10.1006/JMCC.1996.0333
Federico Pieruzzi, Zaid A. Abassi, Harry R. Keiser, Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation. ,vol. 92, pp. 3105- 3112 ,(1995) , 10.1161/01.CIR.92.10.3105
Alan H. Gradman, Karen E. Arcuri, Allan I. Goldberg, Leila S. Ikeda, Edward B. Nelson, Duane B. Snavely, Charles S. Sweet, A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension Hypertension. ,vol. 25, pp. 1345- 1350 ,(1995) , 10.1161/01.HYP.25.6.1345
R Eskay, Z Zukowska-Grojec, M Haass, J. Dave, N Zamir, Circulating atrial natriuretic peptides in conscious rats: regulation of release by multiple factors Science. ,vol. 232, pp. 636- 639 ,(1986) , 10.1126/SCIENCE.2938258
B I Levy, J Benessiano, D Henrion, L Caputo, C Heymes, M Duriez, P Poitevin, J L Samuel, Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Journal of Clinical Investigation. ,vol. 98, pp. 418- 425 ,(1996) , 10.1172/JCI118807
E Clauser, KM Curnow, E Davies, S Conchon, B Teutsch, B Vianello, C Monnot, P Corvol, Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements. European Journal of Endocrinology. ,vol. 134, pp. 403- 411 ,(1996) , 10.1530/EJE.0.1340403